Baylor Scott & White The Heart Hospital - Plano
Plano, Texas, 75093, United States
NCT Number: NCT06829914
The investigators hypothesize that Shockwave with DCB is non-inferior to surgical endarterectomy for common femoral artery (CFA) stenosis with regard to primary efficacy and safety endpoints. The study will challenge the current guideline that recommends common femoral endarterectomy (CFE) as the primary treatment for symptomatic CFA stenosis.
This study is active but is not currently recruiting participants.
Notify Me18 year and older
All sexes
Interventional
Not applicable
Plano, Texas, 75093, United States
This is a pilot, prospective, randomized clinical trial. This trial compares patients with severe symptomatic moderate to severe calcified CFA stenosis undergoing traditional gold standard CFA endarterectomy to innovative technique of endovascular treatment using Shockwave™ Intra vascular Lithotripsy (IVL) using M5+ balloon with Drug coated balloon to achieve removal and debulking of plaque and achieve luminal gain. Patients who meet inclusion criteria will be informed and consented by a clinical coordinator if they wish to participate in the trial. If participants are candidates for surgery, they will then be randomized into one of two cohorts, receiving either Shockwave™ IVL + DCB (drug-coated balloon) procedure or a standard surgical endarterectomy. The study compares the 1-year efficacy and 6-month safety outcomes post-procedure for patients with severe, symptomatic CFA stenosis receiving Shockwave™ IVL with DCB versus surgical endarterectomy.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
A patient will be eligible for inclusion in this study if he or she meets all of the following criteria (confirmed by core lab):
Exclusion criteria
A patient will be ineligible for inclusion in this study if he or she meets any of the following criteria:
Shockwave™ IVL + DCB procedure
Standard CFA endarterectomy
Time frame: Procedure date through 1-year post-op
Time frame: Procedure date through 1-year post-op
Time frame: Procedure date through 30 days post-op
Time frame: Procedure date through 30 days post-op
Time frame: Procedure date through 6 months post-op
Time frame: Procedure date through 1-year post-op
Time frame: 30 days post-op, 3 months post-op, 6 months post-op, 1 year post-op
https://www.ncbi.nlm.nih.gov/books/NBK553864/table/ch20.Tab2/#
Stage 0 - Asymptomatic. Stage 1 - Mild claudication - Completes treadmill exercise; Ankle Pressure (AP) after exercise >50 mmHg but at least 20 mmHg lower than resting value.
Stage 2 - Moderate claudication - Between categories 1 and 3. Stage 3 - Severe claudication - Cannot complete standard treadmill exercise and AP after exercise <50 mm Hg.
Stage 4 - Ischemic rest pain - Resting AP <40 mm Hg, flat or barely pulsatile ankle or metatarsal pulse volume recording (PVR); Toe Pressure (TP) < 30 mm Hg.
Stage 5 - Minor tissue loss-nonhealing ulcer, focal gangrene with diffuse pedal ischemia- Resting AP < 60 mm Hg, ankle or metatarsal PVR flat or barely pulsatile; TP < 40 mm Hg Stage 6 - Major tissue loss-extending above TM level, functional foot no longer salvageable - Same as category 5
Time frame: Pre-op, 30 days post-op, 6 months post-op, 1 year post-op
Measured by the Peripheral Artery Questionnaire (PAQ), a 20-question questionnaire measuring peripheral vascular disease affect on quality of life. Questionnaires may be completed in-person or via phone call conducted by the study coordinator.
Time frame: Intra-op
Time frame: Intra-op
Time frame: Procedure date through 1 year post-op
Time frame: Procedure date through 30 days post-op
Time frame: 30 days post-op, 30 days post-discharge
Time frame: 30 days post-op
Time frame: 30 days post-op, 6 months post-op
Time frame: Procedure date through 30 days post-op
Patients must meet criteria from both sections:
Radiology: One definitive chest radiological exam (x-ray or CT) with at least one of the following:
Patients with underlying pulmonary or cardiac disease require two serial chest radiological exams (x-ray or CT) taken no less than 12 hours apart, but no more than 7 days apart.
Signs/Symptoms/Laboratory: at least one of the following:
Time frame: Procedure date through 30 days post-op
Intubation greater than 48 hours postoperatively
Time frame: Procedure date through 30 days post-op
Must meet one of the following TWO criteria within 30 days of the operation:
AND urine culture of >105 colonies/mL urine with no more than two species of organisms
OR two of the following:
AND any of the following:
Time frame: Procedure date through 30 days post-op
The disorder spectrum spans from relatively mild physiologic abnormalities to septic shock. The most significant level is reported using the following criteria: SIRS (Systemic Inflammatory Response Syndrome), clinically recognized by the presence of two or more of the following in the same time frame:
Temp >38 degrees C or 90 bpm RR >20 breaths/min or PaCO2 12,000 cell/mm3, 10% immature (band) forms anion gap acidosis. Report if the patient has clinical signs and symptoms of SIRS listed above and meets either A or B:
A. One of the following:
B. Suspected pre-operative infection or bowel infarction leading to the surgical procedure. Procedural findings must confirm this suspected diagnosis with one or more of the following:
Time frame: Procedure date through 30 days post-op
Report this variable if the patient has sepsis AND documented organ and/or circulatory dysfunction. Examples of organ dysfunction include: oliguria, acute alteration in mental status, acute respiratory distress. Examples of circulatory dysfunction include: hypotension, requirement of inotropic or vasopressor agents. The presence of pneumatosis along with the presence of SIRS is assigned.
Time frame: Procedure date through 30 days post-op
Mechanical failure of an extracardiac graft or prosthesis including myocutaneous flaps and skin grafts requiring return to the operating room, interventional radiology or a balloon angioplasty within 30 days of the operation.
Time frame: Procedure date through 30 days post-op
The absence of cardiac rhythm or presence of chaotic cardiac rhythm, intraoperatively or postoperatively, which results in a cardiac arrest requiring the initiation of CPR, which includes chest compressions. Patients are included who are in a pulseless VT or Vfib in in which defibrillation is performed and PEA arrests requiring chest compressions. Patients with automated implantable cardioverter defibrillator (AICD) that fire but the patient has no loss of consciousness should be excluded.
Time frame: Procedure date through 30 days post-op
Documentation of one or more of the following changes indicative of acute MI:
Time frame: Procedure date through 30 days post-op
In a patient who did not require dialysis preoperatively, worsening of renal dysfunction postoperatively requiring hemodialysis, peritoneal dialysis, hemofiltration, hemodiafiltration, or ultrafiltration
Time frame: Procedure date through 30 days post-op
Initiation of hemodialysis, peritoneal dialysis, hemofiltration, hemodiafiltration or ultrafiltration in a patient not previously on said therapy preoperatively
Time frame: Procedure date through 30 days post-op
New diagnosis of blood clot or thrombus within the venous system (superficial or deep) which may be coupled with inflammation and requires treatment. Must be noted within 30 days after the principal operative procedure AND one of the following A or B below:
A.New Diagnosis of a [new] venous thrombosis (superficial or deep), confirmed by a duplex, venogram, CT scan, or any other definitive imaging modality (including direct pathology examination such as autopsy) AND the patient must be treated with anticoagulation therapy and/or placement of a vena cava filter or clipping of the vena cava, or the record indicates that treatment was warranted but there was no additional appropriate treatment option available.
B. As per (A) above, but the patient or decisionmaker has refused treatment. There must be documentation in the medical record of the [patient's] refusal of treatment.
Time frame: Procedure date through 30 days post-op
Lodging of a blood clot in the pulmonary artery with subsequent obstruction of blood supply to the lung parenchyma. The blood clots usually originate from the deep leg veins or pelvic venous system. Since there are not always preoperative studies proving that a clot or thrombus was not present preoperatively, the technical specification of the variable requires only a "new diagnosis"- in other words the clot or thrombus was not previously known. A pulmonary embolism must be noted within 30 days after the principal operative procedure AND the following criteria, A AND B below:
A. New diagnosis of a new blood clot in a pulmonary artery
AND
B. The patient has a V-Q scan interpreted as high probability of pulmonary embolism or a positive CT exam, TEE, pulmonary arteriogram, CT angiogram, or any other definitive imaging modality (including direct pathology examination such as autopsy
Baylor Research Institute
Other
Acronym: Shockify
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04745624
Common Femoral Artery Stenosis
New Haven, Connecticut, United States
View Trial DetailsNCT06711822
Calcification; Heart, Calcinosis
Beijing, Beijing Municipality, China
View Trial DetailsNCT07340294
Calcific Coronary Arteriosclerosis, Calcinosis
Nanchang, Jiangxi, China
View Trial DetailsNCT05162742
Aortic Valve Calcification, Aortic Valve Disease
Nijmegen, The Netherlands, Netherlands
View Trial Details